Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycine-containing peptidoglycan cross-links are essential structural motifs in the cell walls of various Gram-positive bacteria, particularly within the genus Staphylococcus [1, 3]. These interpeptide bridges, which often consist of a pentaglycine chain, connect the L-lysine of one stem peptide to the D-alanine of another, providing the mechanical strength required to withstand high internal osmotic pressure [1, 3]. While the pentaglycine bridge is the hallmark of Staphylococcus aureus, similar glycine-rich bridges are found in non-S. aureus species such as S. epidermidis, S. simulans, and S. saprophyticus, although they may occasionally incorporate L-serine or L-alanine [1, 4]. These cross-links are the specific substrate for glycyl-glycine endopeptidases like lysostaphin and ALE-1, which cleave the peptide bonds between glycine residues [2, 4]. The targeted hydrolysis of these bridges leads to the rapid disintegration of the peptidoglycan network, resulting in bacterial lysis [2]. Consequently, these cross-links represent a vulnerable therapeutic target for treating infections caused by coagulase-negative staphylococci, which are increasingly associated with biofilm-mediated infections on medical implants [2, 3].
Hydrolysis of glycyl-glycine peptide bonds within the interpeptide bridge, leading to cell wall degradation and osmotic lysis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine-containing peptidoglycan cross-link.